Recombinant E. Coli Pathway Engineering for High-Yield L-Valine
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current L-valine producing strains, particularly those based on Escherichia coli, suffer from low yield and productivity due to complex regulation mechanisms and cofactor imbalances, limiting their economic competitiveness in microbial fermentation.
Innovation Solution
A recombinant Escherichia coli strain is developed by overexpressing specific transcription regulation factors, enhancing key enzymes, and integrating genes for improved metabolic pathways, including the Entner-Doudoroff pathway, to balance cofactors and optimize L-valine synthesis under controlled oxygen conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional metabolic engineering and mutagenesis are used to construct L-valine producing strains, then L-valine production capability is improved, but yield and productivity remain low
Solution Approach 1:
The invention changes the cofactor balance parameters in the metabolic pathway by introducing heterologous enzymes with different cofactor specificities (NADH-dependent leucine dehydrogenase instead of NADPH-dependent transaminase), thereby improving both yield and productivity of L-valine production
Solution Approach 2:
The invention uses heterologous leucine dehydrogenase from Lactobacillus plantarum as an intermediary enzyme to convert pyruvate to alpha-ketoisovalerate using NADH instead of NADPH, bypassing the rate-limiting step and improving overall productivity
2Quantity of substance
If NADPH-dependent transaminase is used in L-valine synthesis pathway, then L-valine production is achieved, but cofactor imbalance limits yield improvement
Solution Approach 1:
The invention changes the cofactor requirement from NADPH to NADH by replacing transaminase with leucine dehydrogenase, thereby resolving the cofactor imbalance that limited yield improvement in conventional pathways
Solution Approach 2:
The invention substitutes the NADPH-dependent transaminase system with an NADH-dependent leucine dehydrogenase system, replacing the limiting enzymatic mechanism with a more efficient alternative that better matches cellular cofactor availability
3Ease of manufacture
If Escherichia coli is used as production chassis, then genetic background clarity is improved, but complex regulation mechanism reduces L-valine production efficiency
Solution Approach 1:
The invention extracts and removes the regulatory constraints imposed by E. coli's complex control mechanisms on the L-valine pathway, allowing high-level expression of key enzymes without natural repression
Solution Approach 2:
The invention inverts the natural regulation logic by using strong constitutive promoters to drive expression of pathway enzymes, overcoming the endogenous repression mechanisms that normally limit amino acid production in E. coli
4Quantity of substance
If Corynebacterium glutamicum is used as microbial chassis, then L-valine production capability is improved, but production cost and economic competitiveness worsen
Solution Approach 1:
The invention makes E. coli, a universally used and well-characterized chassis organism, capable of efficient L-valine production by introducing optimized pathway genes, thereby eliminating the need to use more expensive or specialized organisms like C. glutamicum
Data Source
AI summary
The invention provides an Escherichia coli for synthesizing L-valine, a construction method and use thereof. The Escherichia coli of the invention is designated as Escherichia coli W3110 and was deposited in China Center for Type Culture Collection (Address: Bayi Road, Wuchang District, Wuhan City, Hubei Province) under the Accession No. CCTCC M 2022293 on Mar. 18, 2022. The recombinant Escherichia coli takes Escherichia coli as a starting strain, and a transcription regulation factor is overexpressed to obtain a recombinant Escherichia coli. The recombinant Escherichia coli for synthesizing L-valine of the invention is fermented in a 5 L fermentor with trace dissolved oxygen to test strains, the yield of L-valine reaches 112 g/L, and the OD of the bacterium is 104.